SEC Form 4 · accession 0001144204-19-012829
MEDIFAST INC · MED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael C Macdonald
Director
Period of report
Mar 5, 2019
Accepted (ET)
Mar 7, 2019 · 8:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910329
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Mar 5, 2019 | S | 6,607 | $130.38 | D | 5,793 | I | Michael C. MacDonald Charitable Remainder Unitrust |
| Common StockF3,F2 | Mar 5, 2019 | S | 2,410 | $131.46 | D | 3,383 | I | Michael C. MacDonald Charitable Remainder Unitrust |
| Common StockF4,F2 | Mar 5, 2019 | S | 2,883 | $132.58 | D | 500 | I | Michael C. MacDonald Charitable Remainder Unitrust |
| Common StockF5,F2 | Mar 5, 2019 | S | 500 | $133.34 | D | 0 | I | Michael C. MacDonald Charitable Remainder Unitrust |
| Common StockF6 | Mar 5, 2019 | S | 3,654 | $130.39 | D | 298,842 | D | |
| Common StockF7 | Mar 5, 2019 | S | 1,200 | $131.44 | D | 297,642 | D | |
| Common StockF8 | Mar 5, 2019 | S | 1,371 | $132.56 | D | 296,271 | D | |
| Common StockF9 | Mar 5, 2019 | S | 200 | $133.30 | D | 296,071 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.00 to $130.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
- F2The shares are held by the Michael C. MacDonald Charitable Remainder Unitrust, dated October 24, 2018, for which the Reporting Person acts as Trustee, and of which the Reporting Person and his wife are beneficiaries. The Reporting Person continues to report beneficial ownership of all of the Issuer Common Stock held by the Trust but disclaims beneficial ownership except to the extent of his and his wife's pecuniary interest therein.
- F3The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.02 to $131.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
- F4The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.02 to $132.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
- F5The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.03 to $133.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
- F6The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $130.005 to $130.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
- F7The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.00 to $131.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
- F8The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.02 to $132.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.
- F9The price reported in Colum 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.02 to $133.57, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range described herein.